Difficulty: Medium
Average Score: 74%
Practice
A 29-year-old man with spinal cord injury and with chronic gastric immotility syndrome has failed therapy with numerous cholinoimimetic agents. He has begun on therapy with physostigmine. Unfortunately, a supratherapeutic dose is administered to the patient. Which of the following effects must the treating physician be aware of?
Correct answer
A
Rationale
The correct answer is A) Convulsions. Physostigmine, a cholinesterase inhibitor, can lead to excessive cholinergic stimulation when given in supratherapeutic doses. This can result in overstimulation of the CNS, leading to convulsions.
Option B) Flaccid paralysis is incorrect because cholinesterase inhibitors like physostigmine typically cause muscle contractions rather than paralysis.
Option C) Pulmonary embolism is unrelated to the pharmacological effects of physostigmine.
Option D) Sinus tachycardia is unlikely with physostigmine overdose as it primarily affects the cholinergic system, not the cardiac system.
Educationally, this question highlights the importance of understanding the pharmacological mechanisms of CNS drugs and the potential adverse effects of cholinesterase inhibitors. It emphasizes the need for precise dosing and monitoring to prevent harmful outcomes in patients, especially those with pre-existing conditions like spinal cord injury and gastric motility issues.
Option B) Flaccid paralysis is incorrect because cholinesterase inhibitors like physostigmine typically cause muscle contractions rather than paralysis.
Option C) Pulmonary embolism is unrelated to the pharmacological effects of physostigmine.
Option D) Sinus tachycardia is unlikely with physostigmine overdose as it primarily affects the cholinergic system, not the cardiac system.
Educationally, this question highlights the importance of understanding the pharmacological mechanisms of CNS drugs and the potential adverse effects of cholinesterase inhibitors. It emphasizes the need for precise dosing and monitoring to prevent harmful outcomes in patients, especially those with pre-existing conditions like spinal cord injury and gastric motility issues.